POINT Biopharma Global Inc. (PNT) has a market capitalization of $1.33B and trades at $12.50. The 52-week range is 6.57-14.35.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of 12, Earnings Per Share (EPS) of $1.04, annual revenue of $226.58M.
The stock has a beta of 0.00, operates in the Healthcare sector.
